Generic placeholder image

Current Topics in Medicinal Chemistry

Editor-in-Chief

ISSN (Print): 1568-0266
ISSN (Online): 1873-4294

TRPV1 Activation is Not An All-Or-None Event: TRPV1 Partial Agonism/Antagonism and Its Regulatory Modulation

Author(s): Peter M. Blumberg, Larry V. Pearce and Jeewoo Lee

Volume 11, Issue 17, 2011

Page: [2151 - 2158] Pages: 8

DOI: 10.2174/156802611796904825

Price: $65

Abstract

TRPV1 has emerged as a promising therapeutic target for pain as well as a broad range of other conditions such as asthma or urge incontinence. The identification of resiniferatoxin as an ultrapotent ligand partially able to dissect the acute activation of TRPV1 from subsequent desensitization and the subsequent intense efforts in medicinal chemistry have revealed that TRPV1 affords a dramatic landscape of opportunities for pharmacological manipulation. While agonism and antagonism have represented the primary directions for drug development, the pharmacological complexity of TRPV1 affords additional opportunities. Partial agonism/partial antagonism, its modulation by signaling pathways, variable desensitization, and slow kinetics of action can all be exploited through drug design.

Keywords: Resiniferatoxin, capsaicin, partial agonist, partial antagonist, TRPV1, efficacy, signaling pathway, asthma or urge incontinence, activation of TRPV1, subsequent desensitization, pharmacological manipulation, agonism and antagonism, slow kinetics of action, drug design


Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy